Prostate cancer cells overexpress fatty acid synthase protein (FASN) and monoacylglycerol lipase (MAGL), both metabolic enzymes that promote the formation and breakdown of lipids, which are now thought to be metabolic oncogenes [79,80,81]. The gene discussed is FASN; the disease is prostate carcinoma.